SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
Top 10 Most Recent Blog Posts
5 Best Performing Stocks Under $10 as of May 7, 2024
Category: Stocks Total Views: 40By : Editor Updated: 05-07-2024
Best Stock Trading Tips for May 2024: Navigating the Market with Confidence
Category: Stocks Total Views: 38By : Editor Updated: 05-07-2024
Top 10 Performing Stocks: Analysis of May 6, 2024
Category: Stocks Total Views: 119By : Editor Updated: 05-06-2024
Today's Stock Market Performance: A Detailed Recap for May 6, 2024
Category: Markets Total Views: 131By : Editor Updated: 05-06-2024
5 Aerospace & Defense Penny Stocks Under $5 to Consider
Category: Stocks Total Views: 140By : Editor Updated: 05-06-2024
A Cynic's Guide to Stock Market Terminology
Category: Markets Total Views: 150By : Editor Updated: 05-06-2024
5 Foundations of Personal Finance: Mastering the Basics
Category: Personal Finance Total Views: 160By : Editor Updated: 05-06-2024
Navigating Tax Deductions: A Freelancer's Guide
Category: Personal Finance Total Views: 136By : Editor Updated: 05-06-2024
The Rise of Green Investing: Opportunities in the Stock Market
Category: Investing Total Views: 160By : Editor Updated: 05-06-2024
5 Cybersecurity Penny Stocks Under $5 to Consider
Category: Stocks Total Views: 261By : Editor Updated: 05-06-2024